• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aptorum Group Limited - Class A Ordinary Shares (NQ:APM)

1.790 +0.180 (+11.18%)
Streaming Delayed Price Updated: 2:32 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Aptorum Group Limited - Class A Ordinary Shares

< Previous 1 2 3 Next >
Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement
July 16, 2025
From Aptorum Group Ltd
Via GlobeNewswire
Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
April 16, 2025
From Aptorum Group Ltd
Via GlobeNewswire
Aptorum Group Limited Announces Pricing of $3.0 Million Registered Direct Offering
January 02, 2025
From Aptorum Group Ltd
Via GlobeNewswire
Aptorum Group Ltd. (NASDAQ: APM) Leading the Way in Wednesday Trading Based on Percentage Gain
March 06, 2024
Via Investor Brand Network
Aptorum Group Ltd. (NASDAQ: APM) Leading the Way in Friday Trading Based on Percentage Gain
August 25, 2023
Via Investor Brand Network
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2024
December 20, 2024
From Aptorum Group Limited
Via Business Wire
Aptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business Update
April 30, 2024
From Aptorum Group Limited
Via Business Wire
Aptorum Group Ltd. (NASDAQ: APM) is One of Thursday Morning’s Most Active Stocks
March 14, 2024
Via Investor Brand Network
Aptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy Business
March 06, 2024
From Aptorum Group Limited
Via Business Wire
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023
December 22, 2023
From Aptorum Group Limited
Via Business Wire
Aptorum Group Limited Announces Results of 2023 Annual General Meeting of Shareholders
December 21, 2023
From Aptorum Group Limited
Via Business Wire
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023
November 16, 2023
From Aptorum Group Limited
Via Business Wire
Aptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital Markets
August 10, 2023
From Aptorum Group Limited
Via Business Wire
Aptorum Group Updates on a Phase 1b/2a Clinical Trial for Repurposed Small Molecule Drug SACT-1 for Neuroblastoma
June 22, 2023
From Aptorum Group Limited
Via Business Wire
Aptorum Group Limited Announces Voluntary Delisting from Euronext Paris
June 09, 2023
From Aptorum Group Limited
Via Business Wire
Aptorum Group Receives Nasdaq Notification of Minimum Stockholders’ Equity Deficiency
May 05, 2023
From Aptorum Group Limited
Via Business Wire
Aptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Group’s Subsidiary Paths Innovations Limited
May 01, 2023
From Aptorum Group Limited
Via Business Wire
Aptorum Group Limited Reports 2022 Fiscal Year End Financial Results and Provides Business Update
April 28, 2023
From Aptorum Group
Via Business Wire
Aptorum Group Enters into Letter of Intent and Term Sheet To Acquire U Group
March 27, 2023
From Aptorum Group Limited
Via Business Wire
Aptorum Group Limited and ASP Isotopes Inc. Interviews to Air on Bloomberg U.S. on the RedChip Money Report(R)
March 17, 2023
Via ACCESSWIRE
Aptorum Group Announces Completion of Pre-IND Discussions with US FDA on its ALS-4, a First-in-Class Small Molecule Drug Targeting Methicillin Resistant Staphylococcus Aureus
March 03, 2023
From Aptorum Group Limited
Via Business Wire
Aptorum Group Announces Completion of End of Phase 1 (EOP1) Meeting with US FDA on its SACT-1, a Repurposed Small Molecule Drug Targeting Neuroblastoma
March 03, 2023
From Aptorum Group Limited
Via Business Wire
Aptorum Group Launches NativusWell®, a Novel Nutraceutical for Menopause, in China
March 02, 2023
From Aptorum Group Limited
Via Business Wire
Aptorum Group Regains Compliance with Nasdaq Minimum Bid Price and Receives Nasdaq Notification of Minimum Market Value of Publicly Held Shares Deficiency
February 10, 2023
From Aptorum Group Limited
Via Business Wire
Aptorum Group Limited to Hold Special Extraordinary Meeting of Shareholders on February 21, 2023
February 06, 2023
From Aptorum Group Limited
Via Business Wire
Aptorum Group Announces 1-for-10 Reverse Stock Split
January 20, 2023
From Aptorum Group Limited
Via Business Wire
Aptorum Group Announces Publication of a Co-authored Paper on its PathsDx Technology - a Rapid-Turnaround Low-Depth Unbiased Metagenomics Sequencing Workflow for Liquid Biopsy based Diagnosis of Infectious Diseases on Illumina Platforms
January 04, 2023
From Aptorum Group Limited
Via Business Wire
Aptorum Group Limited Announces Results of 2022 Annual General Meeting of Shareholders
December 22, 2022
From Aptorum Group Limited
Via Business Wire
Aptorum Group Announces Completion of $3 Million Convertible Note due 2023
December 16, 2022
From Aptorum Group Limited
Via Business Wire
Aptorum Group Announces Offering of $3 Million Convertible Note due 2023
December 09, 2022
From Aptorum Group Limited
Via Business Wire
< Previous 1 2 3 Next >
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap